Diagnosis of Chlamydia
Chlamydia should be diagnosed using nucleic acid amplification tests (NAATs), which are the gold standard with sensitivities of 86-100% and specificities >98% across multiple specimen types 1, 2.
Recommended Specimen Types
For Women:
- First-line options (all equally acceptable):
- Self-collected vaginal swabs (can be done at home or in clinic)
- Clinician-collected endocervical swabs
- Urine specimens (first-catch or clean-catch)
The evidence shows that urine testing with NAATs is at least as sensitive as endocervical or vaginal specimens 1. Self-collected vaginal swabs are FDA-cleared for most NAATs and perform equivalently to clinician-collected specimens 2. A 2021 study confirmed that even clean-catch urine has 86.2% sensitivity and 98.8% specificity for chlamydia 3.
For Men:
- First-line options:
- Urine specimens (preferred - slightly more sensitive than urethral swabs)
- Urethral swabs
Urine testing in men is actually more sensitive than urethral specimens 1.
For Extragenital Sites:
- Rectal swabs for those engaging in receptive anal intercourse
- Pharyngeal swabs for those engaging in oral sex
Important caveat: While NAATs can be used on rectal and pharyngeal specimens, these sites are not FDA-cleared, though they are widely used in clinical practice 1, 2.
Testing Method Details
Use only NAATs - do not use older methods like culture, direct fluorescent antibody, or enzyme immunoassays for routine screening 2. NAATs have superior sensitivity and specificity compared to all other available tests 4, 1.
The same specimen can test for both chlamydia and gonorrhea simultaneously 1.
When Culture Is Still Needed
Maintain culture capability only for:
- Cases of child sexual assault in prepubescent boys
- Rectal and oropharyngeal infections in prepubescent girls
- Suspected gonorrhea treatment failure (not applicable to chlamydia diagnosis but important for co-testing) 2
Point-of-Care Tests: Not Recommended
Do not use commercially available point-of-care rapid tests for chlamydia screening in women - they have unacceptably low sensitivities (12-62.9%) despite high specificities 4. These tests miss too many infections and should not replace NAATs for diagnostic purposes.
Common Pitfalls to Avoid
- Don't rely on symptoms: Most chlamydia infections are asymptomatic, so testing should be based on risk factors and screening guidelines, not clinical presentation 1
- Don't use inadequate specimen types: Avoid using non-validated specimen types or collection methods
- Don't use non-NAAT methods: Older diagnostic methods are obsolete for routine screening
- Don't forget extragenital sites: In patients with relevant sexual practices, test rectal and pharyngeal sites as urogenital testing alone will miss infections 2